Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10470 | 1061 | 30.8 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
793 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES//CARBOCYCLIC NUCLEOSIDES | 12112 |
10470 | 1 | ACYCLIC NUCLEOSIDE PHOSPHONATES//PMEA//CIDOFOVIR | 1061 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACYCLIC NUCLEOSIDE PHOSPHONATES | authKW | 1523400 | 7% | 69% | 77 |
2 | PMEA | authKW | 553094 | 3% | 62% | 31 |
3 | CIDOFOVIR | authKW | 406216 | 7% | 18% | 79 |
4 | ACYCLIC NUCLEOTIDE ANALOGUES | authKW | 332665 | 2% | 68% | 17 |
5 | PMEDAP | authKW | 287782 | 1% | 100% | 10 |
6 | PMEG | authKW | 287782 | 1% | 100% | 10 |
7 | ACYCLIC NUCLEOTIDE ANALOGS | authKW | 267856 | 1% | 85% | 11 |
8 | HPMPC | authKW | 266387 | 2% | 51% | 18 |
9 | BK PROJECT TEAM 21 | address | 245230 | 1% | 61% | 14 |
10 | HPMPA | authKW | 239815 | 1% | 83% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2497 | 30% | 0% | 314 |
2 | Virology | 1822 | 10% | 0% | 110 |
3 | Chemistry, Medicinal | 1788 | 13% | 0% | 135 |
4 | Chemistry, Organic | 1107 | 16% | 0% | 168 |
5 | Chemistry, Multidisciplinary | 580 | 18% | 0% | 186 |
6 | Microbiology | 429 | 10% | 0% | 103 |
7 | Biochemistry & Molecular Biology | 220 | 16% | 0% | 172 |
8 | Oncology | 77 | 7% | 0% | 70 |
9 | Infectious Diseases | 54 | 3% | 0% | 31 |
10 | Dermatology | 33 | 2% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BK PROJECT TEAM 21 | 245230 | 1% | 61% | 14 |
2 | REGA MED | 175679 | 13% | 4% | 137 |
3 | ORGAN CHEM BIOCHEM | 170383 | 18% | 3% | 188 |
4 | MED 0676 | 148001 | 1% | 86% | 6 |
5 | PROJECT TEAM BK 21 | 110991 | 1% | 43% | 9 |
6 | SAN DIEGO VET MED FDN | 86335 | 0% | 100% | 3 |
7 | EQUIPE REPLICASES VIRALES STRUCT MECANISME DRUG | 57556 | 0% | 100% | 2 |
8 | GRP ENZYMOL MOL FONCT | 57556 | 0% | 100% | 2 |
9 | NUCLEOSIDES PHOSPHORYLATED EFFECTORS TEAM | 57556 | 0% | 100% | 2 |
10 | NEW ANTIVIRALS ANTINEOPLAST | 55981 | 1% | 16% | 12 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 55693 | 9% | 2% | 95 |
2 | COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS | 34884 | 9% | 1% | 94 |
3 | ANTIVIRAL RESEARCH | 33992 | 6% | 2% | 64 |
4 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 14852 | 2% | 3% | 16 |
5 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 7913 | 8% | 0% | 81 |
6 | FOLIA BIOLOGICA | 5197 | 2% | 1% | 16 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 1984 | 4% | 0% | 39 |
8 | MEDICINAL RESEARCH REVIEWS | 1645 | 1% | 1% | 7 |
9 | NEOPLASMA | 1105 | 1% | 0% | 11 |
10 | NUCLEOSIDES & NUCLEOTIDES | 1072 | 0% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACYCLIC NUCLEOSIDE PHOSPHONATES | 1523400 | 7% | 69% | 77 | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATES | Search ACYCLIC+NUCLEOSIDE+PHOSPHONATES |
2 | PMEA | 553094 | 3% | 62% | 31 | Search PMEA | Search PMEA |
3 | CIDOFOVIR | 406216 | 7% | 18% | 79 | Search CIDOFOVIR | Search CIDOFOVIR |
4 | ACYCLIC NUCLEOTIDE ANALOGUES | 332665 | 2% | 68% | 17 | Search ACYCLIC+NUCLEOTIDE+ANALOGUES | Search ACYCLIC+NUCLEOTIDE+ANALOGUES |
5 | PMEDAP | 287782 | 1% | 100% | 10 | Search PMEDAP | Search PMEDAP |
6 | PMEG | 287782 | 1% | 100% | 10 | Search PMEG | Search PMEG |
7 | ACYCLIC NUCLEOTIDE ANALOGS | 267856 | 1% | 85% | 11 | Search ACYCLIC+NUCLEOTIDE+ANALOGS | Search ACYCLIC+NUCLEOTIDE+ANALOGS |
8 | HPMPC | 266387 | 2% | 51% | 18 | Search HPMPC | Search HPMPC |
9 | HPMPA | 239815 | 1% | 83% | 10 | Search HPMPA | Search HPMPA |
10 | PHOSPHONIC ACID NUCLEOSIDE | 230226 | 1% | 100% | 8 | Search PHOSPHONIC+ACID+NUCLEOSIDE | Search PHOSPHONIC+ACID+NUCLEOSIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLY, A , (2003) PHOSPHONOMETHOXYALKYL ANALOGS OF NUCLEOTIDES.CURRENT PHARMACEUTICAL DESIGN. VOL. 9. ISSUE 31. P. 2567 -2592 | 217 | 65% | 156 |
2 | HOLY, A , GUNTER, J , DVORAKOVA, H , MASOJIDKOVA, M , ANDREI, G , SNOECK, R , BALZARINI, J , DE CLERCQ, E , (1999) STRUCTURE-ANTIVIRAL ACTIVITY RELATIONSHIP IN THE SERIES OF PYRIMIDINE AND PURINE N-[2-(2-PHOSPHONOMETHOXY)ETHYL] NUCLEOTIDE ANALOGUES. 1. DERIVATIVES SUBSTITUTED AT THE CARBON ATOMS OF THE BASE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 42. ISSUE 12. P. 2064 -2086 | 82 | 79% | 112 |
3 | NAESENS, L , SNOECK, R , ANDREI, G , BALZARINI, J , NEYTS, J , DECLERCQ, E , (1997) HPMPC (CIDOFOVIR), PMEA (ADEFOVIR) AND RELATED ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGUES: A REVIEW OF THEIR PHARMACOLOGY AND CLINICAL POTENTIAL IN THE TREATMENT OF VIRAL INFECTIONS.ANTIVIRAL CHEMISTRY & CHEMOTHERAPY. VOL. 8. ISSUE 1. P. 1-23 | 89 | 69% | 172 |
4 | HOLY, A , VOTRUBA, I , TLOUSTOVA, E , MASOJIDKOVA, M , (2001) SYNTHESIS AND CYTOSTATIC ACTIVITY OF N-[2-(PHOSPHONOMETHOXY)ALKYL] DERIVATIVES OF N-6-SUBSTITUTED ADENINES, 2,6-DIAMINOPURINES AND RELATED COMPOUNDS.COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS. VOL. 66. ISSUE 10. P. 1545 -1592 | 70 | 77% | 36 |
5 | DE CLERCQ, E , (2013) THE ACYCLIC NUCLEOSIDE PHOSPHONATES (ANPS): ANTONIN HOLY'S LEGACY.MEDICINAL RESEARCH REVIEWS. VOL. 33. ISSUE 6. P. 1278-1303 | 55 | 65% | 18 |
6 | DE CLERCQ, E , HOLY, A , (2005) ACYCLIC NUCLEOSIDE PHOSPHONATES: A KEY CLASS OF ANTIVIRAL DRUGS.NATURE REVIEWS DRUG DISCOVERY. VOL. 4. ISSUE 11. P. 928-940 | 64 | 52% | 320 |
7 | DE CLERCQ, E , (2007) THE ACYCLIC NUCLEOSIDE PHOSPHONATES FROM INCEPTION TO CLINICAL USE: HISTORICAL PERSPECTIVE.ANTIVIRAL RESEARCH. VOL. 75. ISSUE 1. P. 1-13 | 62 | 60% | 80 |
8 | HOLY, A , VOTRUBA, I , MASOJIDKOVA, M , ANDREI, G , SNOECK, R , NAESENS, L , DE CLERCQ, E , BALZARINI, J , (2002) 6-[2-(PHOSPHONOMETHOXY)ALKOXY]PYRIMIDINES WITH ANTIVIRAL ACTIVITY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 45. ISSUE 9. P. 1918-1929 | 57 | 79% | 70 |
9 | DE CLERCQ, E , (2011) THE CLINICAL POTENTIAL OF THE ACYCLIC (AND CYCLIC) NUCLEOSIDE PHOSPHONATES. THE MAGIC OF THE PHOSPHONATE BOND.BIOCHEMICAL PHARMACOLOGY. VOL. 82. ISSUE 2. P. 99-109 | 47 | 69% | 54 |
10 | KHANDAZHINSKAYA, A , YASKO, M , SHIROKOVA, E , (2006) THE SYNTHESIS AND ANTIVIRAL PROPERTIES OF ACYCLIC NUCLEOSIDE ANALOGUES WITH A PHOSPHONOMETHOXY FRAGMENT IN THE SIDE CHAIN.CURRENT MEDICINAL CHEMISTRY. VOL. 13. ISSUE 24. P. 2953 -2980 | 60 | 70% | 11 |
Classes with closest relation at Level 1 |